{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:42:54Z","timestamp":1778740974220,"version":"3.51.4"},"reference-count":91,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":1604,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s13311-019-00729-0","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T16:28:28Z","timestamp":1554913708000},"page":"348-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4253-9261","authenticated-orcid":false,"given":"Michelle L.","family":"Hastings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10111","key":"10.1007\/s13311-019-00729-0_bib1","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0140-6736(17)31073-5","article-title":"Global hearing health care: new findings and perspectives","volume":"390","author":"Wilson","year":"2017","journal-title":"Lancet."},{"issue":"9462","key":"10.1007\/s13311-019-00729-0_bib2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0140-6736(05)71047-3","article-title":"Sensorineural hearing loss in children","volume":"365","author":"Smith","year":"2005","journal-title":"Lancet."},{"key":"10.1007\/s13311-019-00729-0_bib3","series-title":"Hereditary Hearing Loss and Deafness Overview","author":"Shearer","year":"1993"},{"issue":"4","key":"10.1007\/s13311-019-00729-0_bib4","first-page":"758","article-title":"Nonsyndromic hearing impairment: unparalleled heterogeneity","volume":"60","author":"Van Camp","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1007\/s13311-019-00729-0_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/gim.2014.2","article-title":"American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss","volume":"16","author":"Alford","year":"2014","journal-title":"Genet Med : Off J Am Coll Med Genet"},{"issue":"4","key":"10.1007\/s13311-019-00729-0_bib6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ajhg.2018.08.006","article-title":"Genomic Landscape and Mutational Signatures of Deafness-Associated Genes","volume":"103","author":"Azaiez","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1007\/s13311-019-00729-0_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00439-016-1648-8","article-title":"Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss","volume":"135","author":"Sloan-Heggen","year":"2016","journal-title":"Hum Genet"},{"issue":"1","key":"10.1007\/s13311-019-00729-0_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/WCO.0000000000000286","article-title":"The vestibular system: balancing more than just the body","volume":"29","author":"Lopez","year":"2016","journal-title":"Curr Opin Neurol"},{"issue":"10","key":"10.1007\/s13311-019-00729-0_bib9","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archinternmed.2009.66","article-title":"Disorders of balance and vestibular function in US adults: data from the National Health and Nutrition Examination Survey, 2001-2004","volume":"169","author":"Agrawal","year":"2009","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1007\/s13311-019-00729-0_bib10","first-page":"138","article-title":"Aging and the peripheral vestibular system","volume":"13","author":"Ji","year":"2018","journal-title":"J Otolaryngol"},{"key":"10.1007\/s13311-019-00729-0_bib11","doi-asserted-by":"crossref","unstructured":"Dillon CF, Gu Q, Hoffman HJ, Ko CW. Vision, hearing, balance, and sensory impairment in Americans aged 70 years and over: United States, 1999-2006. NCHS Data Brief 2010(31):1\u20138.","DOI":"10.1037\/e665372010-001"},{"issue":"1","key":"10.1007\/s13311-019-00729-0_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/lio2.129","article-title":"Health-related quality of life and economic burden of vestibular loss in older adults","volume":"3","author":"Agrawal","year":"2018","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"3","key":"10.1007\/s13311-019-00729-0_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3766\/jaaa.25.3.8","article-title":"Genetics of peripheral vestibular dysfunction: lessons from mutant mouse strains","volume":"25","author":"Jones","year":"2014","journal-title":"J Am Acad Audiol"},{"issue":"5","key":"10.1007\/s13311-019-00729-0_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10162-017-0634-8","article-title":"Emerging Gene Therapies for Genetic Hearing Loss","volume":"18","author":"Ahmed","year":"2017","journal-title":"J Assoc Res Otolaryngol: JARO"},{"key":"10.1007\/s13311-019-00729-0_bib15","doi-asserted-by":"crossref","unstructured":"Akil O, Oursler AE, Fan K, Lustig LR. Mouse Auditory Brainstem Response Testing. Bio Protoc. 2016;6(6).","DOI":"10.21769\/BioProtoc.1768"},{"issue":"8 Pt 2","key":"10.1007\/s13311-019-00729-0_bib16","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/sj.jp.7200439","article-title":"Development of the ear and hearing","volume":"20","author":"Hall","year":"2000","journal-title":"J Perinatol"},{"issue":"11","key":"10.1007\/s13311-019-00729-0_bib17","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/ar.22575","article-title":"Early development of the vertebrate inner ear","volume":"295","author":"Magarinos","year":"2012","journal-title":"Anat Rec (Hoboken)"},{"issue":"6","key":"10.1007\/s13311-019-00729-0_bib18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nchembio.2069","article-title":"A small molecule mitigates hearing loss in a mouse model of Usher syndrome III","volume":"12","author":"Alagramam","year":"2016","journal-title":"Nat Chem Biol"},{"issue":"5","key":"10.1007\/s13311-019-00729-0_bib19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ymthe.2018.03.004","article-title":"Regeneration of Cochlear Hair Cells and Hearing Recovery through Hes1 Modulation with siRNA Nanoparticles in Adult Guinea Pigs","volume":"26","author":"Du","year":"2018","journal-title":"Mol Ther : J Am Soc Gene Ther"},{"key":"10.1007\/s13311-019-00729-0_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.heares.2017.12.010","article-title":"Communication pathways to and from the inner ear and their contributions to drug delivery","volume":"362","author":"Salt","year":"2018","journal-title":"Hear Res"},{"key":"10.1007\/s13311-019-00729-0_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.heares.2018.06.017","article-title":"Anatomical basis of drug delivery to the inner ear","volume":"368","author":"Glueckert","year":"2018","journal-title":"Hear Res"},{"key":"10.1007\/s13311-019-00729-0_bib22","doi-asserted-by":"crossref","unstructured":"Isgrig K, Chien WW. Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse. J Vis Exp 2018(133).","DOI":"10.3791\/56648"},{"issue":"1","key":"10.1007\/s13311-019-00729-0_bib23","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1038\/s41598-018-21233-z","article-title":"Enhanced viral-mediated cochlear gene delivery in adult mice by combining canal fenestration with round window membrane inoculation","volume":"8","author":"Yoshimura","year":"2018","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-019-00729-0_bib24","first-page":"221","article-title":"Surgical Methods for Inner Ear Gene Delivery in Neonatal Mouse","volume":"2019","author":"Isgrig","year":"1937","journal-title":"Methods Mol Biol"},{"key":"10.1007\/s13311-019-00729-0_bib25","doi-asserted-by":"crossref","unstructured":"Akil O, Rouse SL, Chan DK, Lustig LR. Surgical method for virally mediated gene delivery to the mouse inner ear through the round window membrane. J Vis Exp 2015(97).","DOI":"10.3791\/52187-v"},{"issue":"6","key":"10.1007\/s13311-019-00729-0_bib26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ajhg.2016.03.028","article-title":"RNA Interference Prevents Autosomal-Dominant Hearing Loss","volume":"98","author":"Shibata","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1007\/s13311-019-00729-0_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nbt.3801","article-title":"Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c","volume":"35","author":"Pan","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1007\/s13311-019-00729-0_bib28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.heares.2018.03.002","article-title":"Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications","volume":"368","author":"Salt","year":"2018","journal-title":"Hear Res"},{"key":"10.1007\/s13311-019-00729-0_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2016.01.004","article-title":"Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss","volume":"108","author":"Li","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1007\/s13311-019-00729-0_bib30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/000164801300366552","article-title":"Clinical aspects of round window membrane permeability under normal and pathological conditions","volume":"121","author":"Goycoolea","year":"2001","journal-title":"Acta Otolaryngol"},{"issue":"6","key":"10.1007\/s13311-019-00729-0_bib31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000449239","article-title":"Hearing Loss after Round Window Surgery in Mice Is due to Middle Ear Effusion","volume":"21","author":"Zhu","year":"2016","journal-title":"Audiol Neurootol"},{"key":"10.1007\/s13311-019-00729-0_bib32","doi-asserted-by":"crossref","unstructured":"Guo JY, He L, Qu TF, Liu YY, Liu K, Wang GP, et al. Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice. J Vis Exp 2018(135).","DOI":"10.3791\/57351-v"},{"key":"10.1007\/s13311-019-00729-0_bib33","first-page":"13","article-title":"Therapeutic regulation of gene expression in the inner ear using RNA interference","volume":"66","author":"Maeda","year":"2009","journal-title":"Adv Otorhinolaryngol"},{"key":"10.1007\/s13311-019-00729-0_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fnmol.2018.00221","article-title":"Cochlear Gene Therapy for Sensorineural Hearing Loss: Current Status and Major Remaining Hurdles for Translational Success","volume":"11","author":"Zhang","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"14","key":"10.1007\/s13311-019-00729-0_bib35","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1007\/s13311-019-00729-0_bib36","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1007\/s13311-019-00729-0_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-041217-010829","article-title":"Therapeutic Antisense Oligonucleotides Are Coming of Age","volume":"70","author":"Bennett","year":"2019","journal-title":"Annu Rev Med"},{"key":"10.1007\/s13311-019-00729-0_bib38","doi-asserted-by":"crossref","unstructured":"Seth PP, Tanowitz M, Bennett CF. Selective tissue targeting of synthetic nucleic acid drugs. J Clin Invest 2019.","DOI":"10.1172\/JCI125228"},{"issue":"4","key":"10.1007\/s13311-019-00729-0_bib39","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and Mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","journal-title":"Cell."},{"key":"10.1007\/s13311-019-00729-0_bib40","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA Versus miRNA as Therapeutics for Gene Silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1007\/s13311-019-00729-0_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1007\/s13311-019-00729-0_bib42","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1007\/s13311-019-00729-0_bib43","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/hmg\/ddi172","article-title":"In vitro and in vivo suppression of GJB2 expression by RNA interference","volume":"14","author":"Maeda","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"28","key":"10.1007\/s13311-019-00729-0_bib44","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1523\/JNEUROSCI.0782-16.2016","article-title":"Noise-Induced Loss of Hair Cells and Cochlear Synaptopathy Are Mediated by the Activation of AMPK","volume":"36","author":"Hill","year":"2016","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00729-0_bib45","doi-asserted-by":"crossref","unstructured":"Xiong H, Long H, Pan S, Lai R, Wang X, Zhu Y, et al. Inhibition of Histone Methyltransferase G9a Attenuates Noise-Induced Cochlear Synaptopathy and Hearing Loss. Journal of the Association for Research in Otolaryngology : JARO. 2019.","DOI":"10.1007\/s10162-019-00714-6"},{"key":"10.1007\/s13311-019-00729-0_bib46","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fnmol.2018.00469","article-title":"Mitochondrial Calcium Transporters Mediate Sensitivity to Noise-Induced Losses of Hair Cells and Cochlear Synapses","volume":"11","author":"Wang","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"10.1007\/s13311-019-00729-0_bib47","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/ars.2010.3110","article-title":"Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat","volume":"13","author":"Mukherjea","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1007\/s13311-019-00729-0_bib48","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1038\/cddis.2011.63","article-title":"Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation","volume":"2","author":"Kaur","year":"2011","journal-title":"Cell Death Dis"},{"issue":"19","key":"10.1007\/s13311-019-00729-0_bib49","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1007\/s00018-014-1594-3","article-title":"Prevention of cisplatin-induced ototoxicity by the inhibition of gap junctional intercellular communication in auditory cells","volume":"71","author":"Kim","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1007\/s13311-019-00729-0_bib50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.heares.2012.10.011","article-title":"Intra-tympanic delivery of short interfering RNA into the adult mouse cochlea","volume":"296","author":"Oishi","year":"2013","journal-title":"Hear Res"},{"key":"10.1007\/s13311-019-00729-0_bib51","doi-asserted-by":"crossref","unstructured":"Yoshimura H, Shibata SB, Ranum PT, Moteki H, Smith RJH. Targeted Allele Suppression Prevents Progressive Hearing Loss in the Mature Murine Model of Human TMC1 Deafness. Mol Ther : J Am Soc Gene Ther 2019.","DOI":"10.1016\/j.ymthe.2018.12.014"},{"issue":"5","key":"10.1007\/s13311-019-00729-0_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097064","article-title":"A novel DFNA36 mutation in TMC1 orthologous to the Beethoven (Bth) mouse associated with autosomal dominant hearing loss in a Chinese family","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1007\/s13311-019-00729-0_bib53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng842","article-title":"Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function","volume":"30","author":"Kurima","year":"2002","journal-title":"Nat Genet"},{"issue":"3","key":"10.1007\/s13311-019-00729-0_bib54","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nm.3106","article-title":"Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness","volume":"19","author":"Lentz","year":"2013","journal-title":"Nat Med"},{"key":"10.1007\/s13311-019-00729-0_bib55","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fnmol.2018.00300","article-title":"Gene Therapy in Mouse Models of Deafness and Balance Dysfunction","volume":"11","author":"Wang","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1007\/s13311-019-00729-0_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.heares.2018.05.009","article-title":"Outlook and future of inner ear therapy","volume":"368","author":"Devare","year":"2018","journal-title":"Hear Res"},{"issue":"5","key":"10.1007\/s13311-019-00729-0_bib57","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/MOO.0000000000000477","article-title":"Molecular therapy for genetic and degenerative vestibular disorders","volume":"26","author":"Sayyid","year":"2018","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"7687","key":"10.1007\/s13311-019-00729-0_bib58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature25164","article-title":"Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents","volume":"553","author":"Gao","year":"2018","journal-title":"Nature."},{"key":"10.1007\/s13311-019-00729-0_bib59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.heares.2013.06.011","article-title":"Regeneration of mammalian cochlear and vestibular hair cells through Hes1\/Hes5 modulation with siRNA","volume":"304","author":"Du","year":"2013","journal-title":"Hear Res"},{"key":"10.1007\/s13311-019-00729-0_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-pharmtox-010716-104846","article-title":"Pharmacology of Antisense Drugs","volume":"57","author":"Bennett","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1007\/s13311-019-00729-0_bib61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2015.10.015","article-title":"Chemical and structural modifications of RNAi therapeutics","volume":"104","author":"Ku","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1007\/s13311-019-00729-0_bib62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/jpet.113.212407","article-title":"Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates","volume":"350","author":"Rigo","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1007\/s13311-019-00729-0_bib63","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/nat.2016.0656","article-title":"Molecular Mechanisms of Antisense Oligonucleotides","volume":"27","author":"Crooke","year":"2017","journal-title":"Nucleic acid therapeutics"},{"issue":"1","key":"10.1007\/s13311-019-00729-0_bib64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-4781(99)00150-5","article-title":"Morpholino antisense oligomers: the case for an RNase H-independent structural type","volume":"1489","author":"Summerton","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1007\/s13311-019-00729-0_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/17425255.2013.737320","article-title":"Clinical pharmacokinetics of second generation antisense oligonucleotides","volume":"9","author":"Yu","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"18","key":"10.1007\/s13311-019-00729-0_bib66","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1007\/s13311-019-00729-0_bib67","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.tips.2018.09.001","article-title":"Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping","volume":"39","author":"Li","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"10.1007\/s13311-019-00729-0_bib68","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1742-4658.2009.06908.x","article-title":"Ribonuclease H: the enzymes in eukaryotes","volume":"276","author":"Cerritelli","year":"2009","journal-title":"FEBS J"},{"issue":"2","key":"10.1007\/s13311-019-00729-0_bib69","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40262-014-0224-4","article-title":"Clinical and preclinical pharmacokinetics and pharmacodynamics of mipomersen (kynamro((R))): a second-generation antisense oligonucleotide inhibitor of apolipoprotein B","volume":"54","author":"Geary","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1007\/s13311-019-00729-0_bib70","unstructured":"Parham JS, Goldberg AC. Mipomersen and its use in familial hypercholesterolemia. Expert Opin Pharmacother 2018:1\u20135."},{"issue":"1","key":"10.1007\/s13311-019-00729-0_bib71","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1007\/s13311-019-00729-0_bib72","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/GIM.0b013e3181e5afb8","article-title":"Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children","volume":"12","author":"Kimberling","year":"2010","journal-title":"Genet Med : Off J Am Coll Med Genet"},{"issue":"3","key":"10.1007\/s13311-019-00729-0_bib73","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbadis.2014.11.020","article-title":"Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities","volume":"1852","author":"Mathur","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 20","key":"10.1007\/s13311-019-00729-0_bib74","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1242\/jcs.02636","article-title":"Usher I syndrome: unravelling the mechanisms that underlie the cohesion of the growing hair bundle in inner ear sensory cells","volume":"118","author":"El-Amraoui","year":"2005","journal-title":"J Cell Sci"},{"issue":"1","key":"10.1007\/s13311-019-00729-0_bib75","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.exer.2005.11.010","article-title":"Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease","volume":"83","author":"Reiners","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1007\/s13311-019-00729-0_bib76","doi-asserted-by":"crossref","unstructured":"Kremer H, van Wijk E, Marker T, Wolfrum U, Roepman R. Usher syndrome: molecular links of pathogenesis, proteins and pathways. Hum Mol Genet. 2006;15 Spec No 2:R262\u201370.","DOI":"10.1093\/hmg\/ddl205"},{"key":"10.1007\/s13311-019-00729-0_bib77","unstructured":"Ponnath A, Depreux, F.F., Jodelka, F.M., Rigo, F., Farris, H., Hastings, M.L., Lentz, J.J. Rescue of outer hair cells with antisense oligonucleotides in Usher mice is dependent on age of treatment. . J Assoc Res Otolaryngol provisionally accepted."},{"key":"10.1007\/s13311-019-00729-0_bib78","doi-asserted-by":"crossref","unstructured":"Vijayakumar S, Depreux FF, Jodelka FM, Lentz JJ, Rigo F, Jones TA, et al. Rescue of peripheral vestibular function in Usher syndrome mice using a splice-switching antisense oligonucleotide. Hum Mol Genet. 2017;https:\/\/doi.org\/10.1093\/hmg\/ddx234.","DOI":"10.1093\/hmg\/ddx234"},{"key":"10.1007\/s13311-019-00729-0_bib79","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2017.10.012","article-title":"Antisense oligonucleotide therapy rescues disruptions in organization of exploratory movements associated with Usher syndrome type 1C in mice","volume":"338","author":"Donaldson","year":"2018","journal-title":"Behav Brain Res"},{"issue":"20","key":"10.1007\/s13311-019-00729-0_bib80","first-page":"9519","article-title":"Antisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouse","volume":"44","author":"Depreux","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1007\/s13311-019-00729-0_bib81","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/humu.22608","article-title":"Enrichment of LOVD-USHbases with 152 USH2A genotypes defines an extensive mutational spectrum and highlights missense hotspots","volume":"35","author":"Baux","year":"2014","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1007\/s13311-019-00729-0_bib82","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/humu.21634","article-title":"Usher syndrome type 2 caused by activation of an USH2A pseudoexon: implications for diagnosis and therapy","volume":"33","author":"Vache","year":"2012","journal-title":"Hum Mutat"},{"issue":"10","key":"10.1007\/s13311-019-00729-0_bib83","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1038\/mtna.2016.89","article-title":"Antisense Oligonucleotide-based Splice Correction for USH2A-associated Retinal Degeneration Caused by a Frequent Deep-intronic Mutation","volume":"5","author":"Slijkerman","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"10.1007\/s13311-019-00729-0_bib84","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/zeb.2018.1613","article-title":"Poor Splice-Site Recognition in a Humanized Zebrafish Knockin Model for the Recurrent Deep-Intronic c.7595-2144A>G Mutation in USH2A","volume":"15","author":"Slijkerman","year":"2018","journal-title":"Zebrafish."},{"issue":"2","key":"10.1007\/s13311-019-00729-0_bib85","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/humu.22926","article-title":"Whole USH2A Gene Sequencing Identifies Several New Deep Intronic Mutations","volume":"37","author":"Liquori","year":"2016","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1007\/s13311-019-00729-0_bib86","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1006\/exer.2000.0978","article-title":"Spectrum of mutations in USH2A in British patients with Usher syndrome type II","volume":"72","author":"Leroy","year":"2001","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1007\/s13311-019-00729-0_bib87","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1076\/1381-6810(200006)2121-8FT123","article-title":"Prevalence of 2314delG mutation in Spanish patients with Usher syndrome type II (USH2)","volume":"21","author":"Beneyto","year":"2000","journal-title":"Ophthalmic Genet"},{"issue":"12","key":"10.1007\/s13311-019-00729-0_bib88","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/jhg.2009.107","article-title":"Mutation analysis in the long isoform of USH2A in American patients with Usher Syndrome type II","volume":"54","author":"Yan","year":"2009","journal-title":"J Hum Genet"},{"issue":"11","key":"10.1007\/s13311-019-00729-0_bib89","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2006.041764","article-title":"Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II","volume":"43","author":"Aller","year":"2006","journal-title":"J Med Genet"},{"key":"10.1007\/s13311-019-00729-0_bib90","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.heares.2016.06.008","article-title":"A combination of two truncating mutations in USH2A causes more severe and progressive hearing impairment in Usher syndrome type IIa","volume":"339","author":"Hartel","year":"2016","journal-title":"Hear Res"},{"issue":"1","key":"10.1007\/s13311-019-00729-0_bib91","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41598-017-01577-8","article-title":"A deep intronic CLRN1 (USH3A) founder mutation generates an aberrant exon and underlies severe Usher syndrome on the Arabian Peninsula","volume":"7","author":"Khan","year":"2017","journal-title":"Sci Rep"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00729-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-019-00729-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923018809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923018809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00729-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:16:10Z","timestamp":1761808570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923018809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1878747923018809"],"URL":"https:\/\/doi.org\/10.1007\/s13311-019-00729-0","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-019-00729-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}